HOUSTON HPV Trial
Human papillomavirus (HPV) is a cause of many different types of cancers. In men, HPV-related throat cancer is on the rise, and there’s currently no screening test to find it early, when it’s easiest to treat.
MD Anderson Cancer Center is conducting the HOUSTON Trial (HPV-related Oropharyngeal and Uncommon cancers Screening Trial Of meN) to develop a test that can be used to screen for HPV-related throat cancer. To succeed, we need help from men who are willing to participate in the study. Those who sign up will have access to tests that are not available to the general public.
About the HOUSTON HPV Trial
The goal of this clinical research study is to learn about the relationship between human papillomavirus and cancer risk in men who test positive for HPV antibodies. Antibodies are created by the immune system and may attack foreign cells or diseased cells, such as HPV. The goal of the entire study is to learn if screening for HPV can help doctors learn which patients may be at a higher risk for developing throat cancer and other cancers.
HOUSTON HPV Trial eligibility
To participate in this study, you must be:
- Between the ages of 50-64.
- A resident of the United States.
You will be asked to:
- Come to an appointment in the Texas Medical Center (parking costs covered).
- Sign an informed consent document.
- Complete a questionnaire.
- Provide a blood and saliva sample.